Venous Ulcer Treatment Market Report 2024

This Venous Ulcer Treatment market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The venous ulcer treatment market size has grown strongly in recent years. It will grow from $2.88 billion in 2023 to $3.08 billion in 2024 at a compound annual growth rate (CAGR) of 7%. The growth observed in the historic period can be attributed to several factors such as an aging population with a higher incidence of chronic pain conditions, a rise in sports injuries due to increased participation rates, the prevalence of manual labor jobs leading to musculoskeletal disorders, sedentary lifestyles contributing to muscle stiffness and pain, and a lack of exercise causing muscle atrophy and pain.

The venous ulcer treatment market size is expected to see strong growth in the next few years. It will grow to $4.09 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The anticipated growth during the forecast period can be attributed to several factors such as the increasing adoption of non-opioid and non-invasive pain management treatments, rising healthcare expenditures and demand for effective pain management solutions, regulatory approvals for new pain management therapies and devices, a focus on preventive healthcare to address chronic pain conditions, and growing interest in alternative therapies such as acupuncture and chiropractic care. Major trends expected in this period include telehealth and virtual consultations for pain management, the development of wearable pain relief devices and smart clothing, biopharmaceutical innovations in pain treatment, AI-driven personalized pain management solutions, and regenerative medicine techniques for tissue repair and pain reduction.

The growing incidence of chronic diseases is expected to drive the expansion of the venous ulcer treatment market. Chronic diseases are long-lasting health conditions that develop gradually, persist over extended periods, and often require ongoing medical management. The rise in chronic diseases is influenced by factors such as aging populations, sedentary lifestyles, poor dietary habits, increasing obesity rates, and higher prevalence of risk factors such as smoking and excessive alcohol consumption. Venous ulcer treatment addresses and manages ulcers resulting from poor circulation and prolonged venous insufficiency, commonly associated with conditions such as diabetes and chronic venous disease. For example, in January 2023, the National Center for Biotechnology Information (NCBI) projected that the number of individuals aged 50 and above suffering from chronic illnesses will increase by 99.5% by 2050, from 71.52 million in 2020 to 142.66 million. This rising incidence of chronic diseases is fueling growth in the venous ulcer treatment market.

Leading companies in the venous ulcer treatment market are focusing on developing advanced technologies to enhance the effectiveness and convenience of wound care. Dual-syringe systems, which are specialized devices used for the simultaneous or sequential delivery of two substances, are one such innovation. For instance, in March 2024, Integra LifeSciences Holdings Corporation, a US-based medical device company, launched the MicroMatrix Flex dual-syringe system. This system facilitates convenient mixing and precise delivery of treatments, improving access to hard-to-reach areas and ensuring comprehensive care for complex venous ulcers. Its flexible design adapts to various wound shapes and sizes, enhancing coverage and effectiveness while minimizing patient discomfort.

In October 2023, Sanofi S.A., a French pharmaceutical company specializing in venous ulcer treatments, partnered with Teva Pharmaceutical Industries Ltd to advance inflammatory bowel disease treatment. This collaboration combines Sanofi's research and development capabilities with Teva's expertise in generics and biosimilars, potentially accelerating the development of innovative therapies and improving drug accessibility. This partnership also allows both companies to leverage each other's global distribution networks for more efficient product delivery. Teva Pharmaceutical Industries Ltd is an Israel-based pharmaceutical company.

Major companies operating in the venous ulcer treatment market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Medtronic plc, Becton Dickinson and Company, Cardinal Health Inc., Essity Aktiebolag, Medline Industries Inc., Select Medical Holdings Corporation, Smith & Nephew plc, Coloplast A/S, 3M Company, ConvaTec Group plc, Integra LifeSciences Holdings Corporation, Organogenesis Holdings Inc., Mölnlycke Health Care AB, Mimedx Group Inc., Tissue Regenix Group plc.

North America was the largest region in the venous ulcer treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the venous ulcer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the venous ulcer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Venous ulcer treatment encompasses medical and therapeutic approaches designed to heal venous ulcers, which are chronic wounds typically caused by poor blood circulation in the veins of the legs. The goal of venous ulcer treatment is to manage symptoms, promote wound healing, improve venous circulation, and prevent recurrence. This is achieved through methods such as compression therapy, wound care, medication, and lifestyle changes.

The primary types of ulcers addressed in venous ulcer treatment include arterial ulcers, neurotropic ulcers, venous ulcers, and diabetic ulcers. Arterial ulcers are painful sores that develop on the legs or feet due to poor blood flow from narrowed or blocked arteries. These ulcers typically appear in areas with minimal cushioning, such as the toes, heels, or bony parts of the feet. Various treatment methods, including compression therapy, surgical therapy, skin grafting, and advanced wound dressing, are utilized in different settings such as hospitals, clinics, and home care environments.

The venous ulcer treatment market research report is one of a series of new reports that provides venous ulcer treatment market statistics, including venous ulcer treatment industry global market size, regional shares, competitors with a venous ulcer treatment market share, detailed venous ulcer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the venous ulcer treatment industry. This venous ulcer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The venous ulcer treatment market includes revenues earned by entities by providing services such as wound care, physical therapy, pharmacological treatments, and monitoring and follow-up services, and related hydrotherapy devices, debridement tools, topical medications, and wound dressings. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.